The Moderna corporation announced in June 2023 that it filed for FDA authorization of its monovalent XBB. 1.5 vaccine.
Pfizer also announced the same message in August. It’s on page 4 of the Pfizer Earnings Call.
Author: James Amos
I'm a retired consult-liaison psychiatrist. I navigated the path in a phased retirement program through the hospital where I was employed. I was fully retired as of June 30, 2020. This blog chronicles my journey.
View all posts by James Amos